Literature DB >> 5822593

Control of insulin secretion during fasting hyperglycemia in adult diabetics and in nondiabetic subjects during infusion of glucose.

C J Goodner, M J Conway, J H Werbach.   

Abstract

In obese adult diabetics, the concentration of insulin in venous plasma was unrelated to the degree of hyperglycemia after an overnight fast. However, in these subjects, insulin rose and fell in proportion to the magnitude of change in plasma glucose induced by small intravenous infusions of glucose. The minimal dose of glucose to cause a significant rise in insulin above the fasting level was similar in normal subjects, obese nondiabetic subjects, and in obese, hyperglycemic adult diabetics. This dose lay between infusion of 60 and 100 mg of glucose per min for 30 min. These results suggested that the secretion of insulin was under regulation by changes in blood glucose but was not stimulated in proportion to the stable raised blood glucose concentration of the hyperglycemic diabetic. Artificial hyperglycemia was induced in fasting normal subjects by constant intravenous infusion of glucose at rates of 100-250 mg of glucose per min for periods up to 8 hr. Plasma glucose rose during the 1st hr of infusion and then remained constantly elevated for up to 8 hr. The concentration of plasma insulin paralleled that of plasma glucose. During the period of constant hyperglycemia and elevated insulin, superimposition of a brief additional glucose load resulted in a prompt rise in glucose and insulin, both returning to the previous elevated levels. Thus in normals as well as obese diabetics, stable hyperglycemia does not produce a pancreatic response sufficient to return the blood glucose to an arbitrary normal fasting concentration, yet the beta cells remain readily responsive to a change in plasma glucose. These data suggest that the beta cells do not operate as a control system with an absolute reference point when presented with systemic hyperglycemia. The behavior of the beta cells during hyperglycemia in the fasting obese adult diabetic suggests that the regulation of the basal insulin secretion may not be determined by factors directly related to the prevailing concentration of glucose. It is postulated that the beta cells adapt to hyperglycemia perhaps through the operation of controls directed toward a normal delivery of free fatty acids or some other cellular metabolic substrate during fasting.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5822593      PMCID: PMC322424          DOI: 10.1172/JCI106154

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Serum immunoreactive insulin response during prolonged glucose infusions in nondiabetic and diabetic humans.

Authors:  A L Graber; F C Wood; R H Williams
Journal:  Diabetes       Date:  1967-03       Impact factor: 9.461

2.  The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus.

Authors:  E Cerasi; R Luft
Journal:  Acta Endocrinol (Copenh)       Date:  1967-06

Review 3.  Insulin and the pancreas.

Authors:  G M Grodsky; P H Forsham
Journal:  Annu Rev Physiol       Date:  1966       Impact factor: 19.318

4.  Intestinal factors in the control of insulin secretion.

Authors:  N McIntyre; C D Holdsworth; D S Turner
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

5.  An in vitro method for studying insulin secretion in the perfused isolated rat pancreas.

Authors:  K E Sussman; G D Vaughan; R F Timmer
Journal:  Metabolism       Date:  1966-05       Impact factor: 8.694

6.  The effect of epinephrine on immunoreactive insulin levels in man.

Authors:  D Porte; A L Graber; T Kuzuya; R H Williams
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808

7.  Insulin secretion in obesity.

Authors:  R A Kreisberg; B R Boshell; J DiPlacido; R F Roddam
Journal:  N Engl J Med       Date:  1967-02-09       Impact factor: 91.245

8.  Effects of prolonged fasting on insulin secretion.

Authors:  S M Genuth
Journal:  Diabetes       Date:  1966-11       Impact factor: 9.461

9.  Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.

Authors:  H S Seltzer; E W Allen; A L Herron; M T Brennan
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

10.  A receptor mechanism for the inhibition of insulin release by epinephrine in man.

Authors:  D Porte
Journal:  J Clin Invest       Date:  1967-01       Impact factor: 14.808

View more
  9 in total

1.  Exploration of the early insulin response by two small successive loads of I.V. glucose in normal and obese subjects.

Authors:  R Prando; R Cordera; P Odetti; A De Micheli; M Maiello; G Viviani; L Adezati
Journal:  Acta Diabetol Lat       Date:  1978 Jan-Apr

2.  [Plasma lipid pattern in diabetics before and after insulin treatment: total lipids, triglycerides, phospholipids, and -lipoprotein cholesterol and single NEFA (C 16 -C 18 )].

Authors:  A M Bertolini; A Santagostino
Journal:  Acta Diabetol Lat       Date:  1972 May-Jun

3.  No glucotoxicity after 53 hours of 6.0 mmol/l hyperglycaemia in normal man.

Authors:  H Flax; D R Matthews; J C Levy; S W Coppack; R C Turner
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

4.  Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.

Authors:  J P Palmer; J W Benson; R M Walter; J W Ensinck
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

5.  Control of basal insulin secretion, with special reference to the diagnosis of insulinomas.

Authors:  R C Turner; N W Oakley; J D Nabarro
Journal:  Br Med J       Date:  1971-04-17

6.  Glucose control of basal insulin secretion in diabetes.

Authors:  S T McCarthy; E Harris; R C Turner
Journal:  Diabetologia       Date:  1977-04       Impact factor: 10.122

7.  The FOXP1, FOXP2 and FOXP4 transcription factors are required for islet alpha cell proliferation and function in mice.

Authors:  Jason M Spaeth; Chad S Hunter; Lauren Bonatakis; Min Guo; Catherine A French; Ian Slack; Manami Hara; Simon E Fisher; Jorge Ferrer; Edward E Morrisey; Ben Z Stanger; Roland Stein
Journal:  Diabetologia       Date:  2015-05-29       Impact factor: 10.122

8.  Driver versus navigator causation in biology: the case of insulin and fasting glucose.

Authors:  Manawa Diwekar-Joshi; Milind Watve
Journal:  PeerJ       Date:  2020-12-11       Impact factor: 2.984

9.  Circulating lipids in men with type 2 diabetes following 3 days on a carbohydrate-free diet versus 3 days of fasting.

Authors:  Frank Q Nuttall; Rami M Almokayyad; Mary C Gannon
Journal:  Physiol Rep       Date:  2020-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.